MedWatch

2curex opens the gates to Asia and gets patent in Hong Kong

Danish firm 2curex is keeping a close eye on Asia as a possible new market. The company has developed a test to ensure patients get the most effective cancer treatments, and with a newly issued patent the company has taken its first steps to success.

2curex has developed a test to ensure that cancer patients get the most effective treatment. Photo: Modelfoto/Colourbox.com

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles